Value Partners Group
Hong Kong SARvaluepartners-group.com
Overview
Value Partners Group is a Hong Kong-based asset management firm founded in 1993. It is listed on the Hong Kong Stock Exchange (SEHK: 806) and was the first asset management firm to do so. The firm primarily employs a value investing strategy and offers a range of investment products covering equities, fixed income, multi-asset, alternatives, and quantitative solutions, with a focus on Greater China and Asia. It serves both institutional and individual clients globally, with offices in Hong Kong, Beijing, Shanghai, Shenzhen, Singapore, Kuala Lumpur, and London.
Portfolio Companies
4
Website
valuepartners-group.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Insilico Medicine | Jun 2025 | Series E | Lead |
| PHASE Scientific International Limited | May 2025 | Series A | Lead |
| Insilico Medicine | Mar 2025 | Series E | Lead |
| Insilico Medicine | Jan 2025 | Series E | Lead |
| TJ Biopharma | Jul 2022 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
